Garret Stuber Named Co-Recipient of the Waletzky Award
The Jacob P. Waletzky Award is given to a young scientist (within 15 years of his/her PhD or MD degree) whose independent research has led to significant conceptual and empirical contributions to the understanding of drug addiction.
New Theory Addresses How Life on Earth Arose from the Primordial Muck
UNC School of Medicine's Charles Carter and New Zealand's Peter Wills use experimental evidence to overturn widely accepted theory on the dawn of life on Earth.
How do adult brain circuits regulate new neuron production?
In a new study published in Cell Stem Cell, UNC School of Medicine neuroscientist Juan Song and colleagues discovered a long-distance brain circuit that controls the production of new neurons in the hippocampus.
Simple Genetic Test Promises Better Outcomes in Heart Stent Patients
A study co-authored by Rick Stouffer, III, MD, the Henry A. Foscue Distinguished Professor of Medicine, chief of cardiology at UNC, highlights potential of personalized medicine in patients with cardiovascular disease.
Gopal to be Winter Commencement speaker
Dr. Satish Gopal, an innovative cancer researcher on the forefront of cancer treatment in Malawi, will be the featured speaker at UNC's Winter Commencement ceremony.
Researchers Compile Scientific Evidence Behind “Nine Truths About Eating Disorders” Ahead of National Eating Disorder Conference
To better educate the public and physicians on what is and isn’t true about eating disorders, UNC’s Cynthia Bulik and fellow researchers delved into the science to substantiate the “Nine Truths About Eating Disorders.”
New study aims to reduce opioid use while managing chronic pain
A principal investigator of the study is UNC’s Dr. Paul Chelminski, a professor at the UNC School of Medicine with extensive experience studying best practices of prescribing and managing long-term opioid use.
Buse leads clinical trial of new type 1 diabetes treatment
The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.
Researchers use a skin patch, infrared light, and melanin to battle melanoma
In lab experiments led by Zhen Gu, PhD, UNC and NC State scientists were able to trigger naturally occurring melanin to boost an immune response against skin cancer cells in mice.
Fat Cell Gene Deficiency Promotes Obesity
UNC School of Medicine’s Damaris Lorenzo, PhD, and colleagues show how a gene variant can trigger obesity in mice – without them eating more than control mice – and lead to health concerns related to weight gain.
Can asthma be controlled with a vitamin supplement?
UNC School of Medicine researchers led by Michelle Hernandez, MD, found that asthma patients taking a kind of vitamin E called gamma tocopherol had less inflammation of the airways. The study points to a new way to control asthma’s chronic symptoms.
A New Test to Measure the Effectiveness of CF Drugs
A new lab model developed by UNC’s Carla Ribeiro, PhD, and colleagues can be used to test new therapeutics for cystic fibrosis.
Muñoz receives Fuller Award
Cristina Muñoz, MD, associate professor of Obstetrics and Gynecology, has been honored with this year’s H. Fleming Fuller Award. Muñoz received the award on Nov. 13 at a meeting of the UNC Health Care Board of Directors.
Could this Protein Protect People against Coronary Artery Disease?
Research led by UNC’s Jonathan Schisler, PhD, showed much lower levels of the protein CXCL5 in older people with clogged arteries.
How to Reverse Protein Clumping, a hallmark of ALS
Watch this UNC School of Medicine Science Short featuring Todd Cohen, PhD, and his lab's work on the underpinnings of two debilitating diseases.
UNC School of Medicine Professors Elected as AAAS Fellows
Blossom Damania and Mark Zylka have been recognized by the world’s largest general scientific society for their contributions to the fields of biological and medical sciences.
New simple test could help cystic fibrosis patients find best treatment
In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique developed in the lab of Martina Gentzsch, PhD, shows promise as a fast, inexpensive indicator to help more patients access new treatments.
The Leukemia & Lymphoma Society awards grant to Savoldo for immunotherapy research
A grant from The Leukemia & Lymphoma Society will help fund clinical research led by UNC Lineberger's Barbara Savoldo, MD, PhD, into an investigational chimeric antigen receptor (CAR) T-cell treatment for acute lymphoblastic leukemia that would include a built-in "safety switch."
Pairing cancer genomics with cognitive computing highlights potential therapeutic options
Study findings suggest that cognitive computing could help physicians to stay abreast of an ever-expanding body of scientific literature as well as highlight potential cancer therapeutic options. UNC Lineberger's William Kim, MD, is the study's corresponding author.
Celebrating Student Research
The 50th annual Student Research Day was held on Nov. 17. Medical Students had the opportunity to showcase their summer research work.
Addressing the burden of glaucoma in Ghana
Rates of glaucoma in Ghana are the second highest in the world. For more than 20 years, Don Budenz, Chair of the Department of Ophthalmology, has traveled to the West African nation to treat patients, train providers, and raise public awareness of the condition.
Inaugural Class of UNC Physician Assistant Program Featured by Blue Cross and Blue Shield of NC
An article published on the BCBS website focuses on one upcoming graduate’s experience in the program, her motivation for pursuing a career as a physician assistant, and her goals after graduating this December.
The Hunt for a Cure to HIV
In recognition of World AIDS Day on Dec. 1, UNC Health Care and our friends at StoryDrivenMedia created this video featuring HIV Cure Center researchers David Margolis, MD, and Nancie Archin, PhD, as well as clinical trial participant Rob Hill.
NIH renews grant funding the Bowles Alcohol Research Center
The center, established 20 years ago and led by Fulton Crews, PhD, will receive more than $8.7 million over five years to continue research on the effects of alcohol on the brain.
Share This: